ARMP · Armata Pharmaceuticals Inc
United States · RS rating 7 · As of 2026-10-14
| Price | 2.78 USD |
|---|---|
| 1-day change | -10.3% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 4 / 14 / 28 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 16 / 36 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | +91.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +81.2% |
| Market cap (USD) | $495.6M |